Pylarify (piflufolastat F-18)
Ended Awarded Last action
- Contract number
- 36C24422N0628
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $87,839
Award facts
- Contract value 100% obligated
- $87,839.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lebanon, PA 17042, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$158,111 | |
| Original award | $245,950 |
About this award
This is a federal contract award to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc. The contract is for the radiopharmaceutical product PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The contract has a ceiling value of $87,839.25 and is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
The contract is awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 4 (VISN 4), a civilian agency. It is not a set-aside contract. Lantheus Holdings, Inc., the parent company of Progenics Pharmaceuticals, is an active federal contractor providing various radiopharmaceuticals, nuclear medicine supplies, and diagnostic imaging agents to government healthcare providers, including the VA, Defense Health Agency (DHA), and National Institutes of Health (NIH) Clinical Center.
Quick answers
Who was awarded contract 36C24422N0628?
36C24422N0628 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 4 (Veterans Health Administration) on May 12, 2022.
How much is contract 36C24422N0628 worth?
The government has obligated $87,839 on 36C24422N0628.
Is contract 36C24422N0628 an order under another contract?
Yes. 36C24422N0628 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24422N0628 competed?
The extent of competition for 36C24422N0628 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award